Balyasny Asset Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$484K Sell
6,802
-12,342
-64% -$973K ﹤0.01% 2383
2025
Q4
$1.57M Buy
19,144
+9,019
+89% +$703K ﹤0.01% 1987
2025
Q3
$760K Sell
10,125
-778,163
-99% -$58M ﹤0.01% 2230
2025
Q2
$58.4M Buy
+788,288
New +$54.9M 0.09% 283
2023
Q3
Sell
-100,848
Closed -$8.19M 2423
2023
Q2
$8.19M Buy
100,848
+95,473
+1,776% +$7.62M 0.02% 865
2023
Q1
$441K Buy
+5,375
New +$384K ﹤0.01% 1986

Other funds holding GEHC

Balyasny Asset Management's GEHC Position: Q1 2026 in Review

Balyasny Asset Management reduced its GE HealthCare (GEHC) stake by 64% in Q1 2026, selling an estimated $973K and leaving 6,802 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #2383.

Balyasny Asset Management first reported a position in GEHC in Q1 2023 and has held it in 6 quarters since. The position peaked at $58.4M in Q2 2025. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Balyasny Asset Management held 6,802 shares of GE HealthCare worth $484K as of Q1 2026.
  • Balyasny Asset Management sold 12,342 GE HealthCare shares in Q1 2026, an estimated $973K.
  • GE HealthCare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2383 holding.
  • Balyasny Asset Management first reported a position in GE HealthCare in Q1 2023 and has held it in 6 quarters since.
  • Balyasny Asset Management's GE HealthCare position peaked at $58.4M in Q2 2025.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.